Bacillus velezensis LMY3-5 and application thereof

Through the application of Bacillus Bacillus Bacillus LMY3-5 and its fermentation broth, the prevention and treatment of soft rot after harvest of kiwi fruit was solved, effective inhibition of various bacteria and prevention and treatment of fruit rot was achieved, and chemical fungicides were replaced to avoid Environmental pollution and drug resistance issues.

CN118956636APending Publication Date: 2024-11-15贵州省山地资源研究所
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202410393494.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-02
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing technology cannot effectively prevent and treat post-harvest soft rot of kiwifruit. The use of traditional chemical fungicides leads to the emergence of drug-resistant pathogens and environmental pollution, and lacks broad-spectrum and safe prevention and control measures.

Method used

A Bacillus Bacillus Bacillus strain LMY3-5 and its fermentation broth have broad-spectrum antibacterial activity and can effectively antagonize a variety of kiwi soft rot bacteria, and are used to prepare preparations for inhibiting and preventing and treating kiwi soft rot.

Benefits of technology

Bacillus Bacillus LMY3-5 fermentation broth has an antibacterial rate of more than 52.18% for kiwi soft rot bacteria, especially for fruit lesions, which can reach up to 73.59%, significantly delaying the rot of kiwi fruit and replacing traditional chemical fungicides. use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956636A_ABST
    Figure CN118956636A_ABST
Patent Text Reader

Abstract

The invention discloses a bacillus velezensis LMY3-5, which is preserved in the China General Microbiological Culture Collection Center (CGMCC) with the preservation number of CGMCC N0: 29700, and the invention also provides a fermentation broth of the bacillus velezensis strain and a secondary metabolite of the strain generated by fermentation of the fermentation broth. The bacillus velezensis strain and the secondary metabolite produced by fermentation of the strain have broad-spectrum bacteriostatic activity, and have good antagonistic action on actinidia soft rot, meaustralian monilinia sclerotiorum, cruciferae alternaria alternata and colletotrichum gloeosporioides, and the bacteriostasis rate reaches 52.18% or above; particularly, the highest inhibition rate on scab on the kiwi fruit can reach 73.59%, and the bacillus subtilis is a potential biological agent for preventing and treating the soft rot of the kiwi fruit and has good development prospect and application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biological control technology, specifically relating to a Bacillus belye LMY3-5 and its applications. Background Technology

[0002] Kiwifruit, also known as Chinese gooseberry, is internationally renowned as the "King of Fruits" due to its unique flavor, rich content of Vitamin C, dietary fiber, and various minerals, as well as its beneficial effects on digestion and stomach health. Currently, over 30 countries worldwide produce kiwifruit, with China having the largest cultivation area and yield. However, with the gradual expansion of kiwifruit cultivation, kiwifruit diseases are also increasing, especially post-harvest soft rot, which causes an average incidence rate of 40-50% of the fruit to rot during storage and sales. To date, this disease has not been effectively controlled in any producing region worldwide, severely impacting the quality and yield of kiwifruit and causing significant economic losses. This disease can be caused by fungi such as *B. dothidea*, *D. eres*, *A. alternata*, and *Phomopsis phragmitis*, either alone or in combination, infecting the young fruit and manifesting symptoms during storage. *B. dothidea* is the primary pathogen. Currently, the use of chemical fungicides remains the main strategy for controlling post-harvest soft rot in kiwifruit. The widespread and long-term use of fungicides has led to the emergence of drug-resistant pathogens and environmental pollution. Therefore, finding a safe, broad-spectrum, and more effective agent for controlling soft rot in kiwifruit is of great significance.

[0003] In recent years, biological control has been extensively researched and applied in the control of fruit and vegetable diseases due to its outstanding advantages such as easy decomposition, no residue, and low likelihood of developing resistance. Among biocontrol bacteria, Bacillus is the most successful and widely used. Previous studies have shown that Bacillus can produce various secondary metabolites, such as bacteriocins, cell wall degrading enzymes, lipopeptide antibiotics, and polypeptides. Lipopeptides can damage fungal cell walls and cell membranes, causing leakage of cell contents and leading to cell death. Bacillus can also synthesize metabolites that promote plant growth, such as indole-3-acetic acid, auxins, cytokinins, and gibberellins. Yan Li et al. isolated strain 9001 (Bacillus amyloliquefaciens) from healthy apples, which showed inhibitory effects against the apple rot pathogen (B. dothidea). Strain JX-5 (Brevibacillus laterosporus) inhibits the growth of Staphylococcus aureus by secreting antibacterial active ingredients. Therefore, exploring green, efficient, and safe disease control measures to replace traditional chemical fungicides and reduce risks such as pesticide residues and environmental pollution has great research prospects and application potential.

[0004] Patent publication number CN116970521A discloses a *Bacillus velezensis* GUMHT p116 and its applications. The *Bacillus velezensis* GUMHT p116 has the accession number CCTCCM No: 2023748. This invention also discloses the application of *Bacillus velezensis* GUMHT p116 in the prevention and control of soft rot and canker in kiwifruit, and its application in the production of lipopeptide antibacterial substances. The *Bacillus velezensis* GUMHT p116 of this invention exhibits good antibacterial effects against soft rot and canker in kiwifruit.

[0005] Patent publication number CN115927082A discloses a strain of Bacillus belyssus YJK1 and its uses. Bacillus belyssus YJK1 significantly inhibits the growth of *Colletotrichum camelliae* and *Colletotrichum fructicola*, reducing the germination rate of their conidia. The fermentation broth of this strain exhibits good stability, resistance to ultraviolet radiation, acids and alkalis, and heat. It shows a significant inhibitory effect on anthracnose leaf lesions, achieving a control efficacy of 90.8% against anthracnose in tea.

[0006] However, none of the aforementioned Bacillus belyssus species have broad-spectrum activity, which greatly limits the scope and value of its application. Summary of the Invention

[0007] To address the shortcomings of existing technologies, this invention proposes a strain of Bacillus belyssus, its secondary metabolites, and their applications. This strain and its fermented secondary metabolites exhibit broad-spectrum antibacterial activity and good antagonistic effects against a variety of pathogens.

[0008] Specifically, this is achieved through the following technical solutions:

[0009] The first objective of this invention is to provide a Bacillus velezensis strain, named Bacillus velezensis LMY3-5, which is deposited at the China General Microbiological Culture Collection Center with accession number CGMCC No:29700.

[0010] A second objective of the present invention is to provide the fermentation broth of the aforementioned Bacillus belyssus LMY3-5.

[0011] A third objective of this invention is to provide secondary metabolites produced by the fermentation of the aforementioned Bacillus belyssus LMY3-5.

[0012] The fourth objective of this invention is to provide the application of the above-mentioned Bacillus belyssus LMY3-5 and / or fermentation broth in antagonizing plant pathogens, wherein the plant pathogens are *Actinidia dothidea*, *D. eres*, *M. fructicola*, and *Australopithecus fructicola*. A.alternata ), tea anthrax bacteria (C. gloeosporioides).

[0013] Specifically, the application of the aforementioned Bacillus vesiculosus LMY3-5 and / or fermentation broth in the preparation of agents that inhibit plant pathogens, wherein the plant pathogens are Actinobacter dothidea, Actinobacter eres, M. fructticola, A. alternata, and C. gloeosporioides.

[0014] The fifth objective of this invention is to provide the application of the above-mentioned Bacillus belye LMY3-5 and / or fermentation broth in the preparation of formulations for controlling diseases caused by plant pathogens, wherein the plant pathogens are Actinobacter dothidea, Actinobacter eres, M. fructticola, A. alternata, and C. gloeosporioides.

[0015] The sixth objective of this invention is to provide the application of the above-mentioned Bacillus vesiculosus LMY3-5 and / or fermentation broth in delaying the decay of kiwifruit.

[0016] The seventh objective of this invention is to provide the application of the above-mentioned Bacillus vesicle LMY3-5 and / or fermentation broth in the preparation of a preventive agent for kiwifruit rot.

[0017] The eighth objective of this invention is to provide the application of secondary metabolites produced by the fermentation of Bacillus belye LMY3-5 in delaying the decay of kiwifruit.

[0018] The ninth objective of this invention is to provide the application of the secondary metabolites produced by the fermentation of Bacillus belye LMY3-5 in the preparation of an agent to delay the decay of kiwifruit.

[0019] The rotting of the kiwifruit was caused by infection with the kiwifruit soft rot fungus (B. dothidea).

[0020] The tenth objective of this invention is to provide a biocontrol agent comprising the aforementioned Bacillus belyssus LMY3-5, and / or the aforementioned fermentation broth, and / or the aforementioned secondary metabolites produced by fermentation.

[0021] Beneficial effects:

[0022] The Bacillus berberis LMY3-5, fermentation broth, or secondary metabolites provided by this invention have broad-spectrum antibacterial activity and exhibit good antagonistic effects against kiwifruit soft rot fungus, Australian and American type stone fruit brown rot fungus, cruciferous black spot fungus, and tea anthracnose fungus, with an inhibition rate of over 52.18%, especially against kiwifruit lesions, where the inhibition rate can reach up to 73.59%. Attached Figure Description

[0023] Figure 1 Figure 3 shows the colony morphology observation results in Example 3;

[0024] Figure 2 Example 5: The inhibitory effect of Bacillus vesicle LMY3-5 fermentation broth on the mycelial growth of the pathogen causing soft rot of kiwifruit.

[0025] Figure 3 Example 6: Effect of Bacillus vesicles LMY3-5 fermentation broth on spore germination inhibition of kiwifruit soft rot pathogen; where A is CK, B is 4.00%, C is 8.00%, and D is 16.00%.

[0026] Figure 4 Example 7 shows the effect of Bacillus belyss LMY3-5 fermentation broth on the control of kiwifruit; where A and B represent the inhibitory effect on the spread of B. dothidea lesions, and C and D represent the inhibitory effect on the spread of D. eres lesions.

[0027] Figure 5 SEM images of Bacillus dothidea mycelial morphology in the fermentation broth of Bacillus belyss LMY3-5 in Example 8; where A is the control group and B is the fermentation broth treatment group;

[0028] Figure 6 TEM images of the ultrastructure of B. dothidea cells in the fermentation broth of Bacillus belyss LMY3-5 in Example 9; where A and B are control groups, and C and D are fermentation broth treatment groups;

[0029] Figure 7 Figure 10: Effect of Bacillus belyss LMY3-5 fermentation broth on B. dothidea cell membrane integrity.

[0030] Figure 8Example 11: Determination of nucleic acid and protein release from Bacillus dothidea in fermentation broth of Bacillus belyss LMY3-5; where A represents nucleic acid and B represents protein.

[0031] Figure 9 The effect of Bacillus belyss LMY3-5 fermentation broth on the activities of B. dothidea glucanase and chitinase in Example 12; where A is β-1,3-glucanase and B is chitinase.

[0032] Figure 10 Example 14: Antibacterial activity of Bacillus belyss LMY3-5 against multiple pathogens. Detailed Implementation

[0033] The specific embodiments of the present invention will be described in further detail below, but the present invention is not limited to these embodiments. Any improvements or substitutions based on the basic spirit of these embodiments shall still fall within the scope of protection claimed by the claims of the present invention.

[0034] Example 1

[0035] A biocontrol bacterial strain, named Bacillus velezensis LMY3-5 (hereinafter also referred to as LMY3-5), is deposited at the China General Microbiological Culture Collection Center (CGMCC) with accession number CGMCC N0:29700, on January 24, 2024, at the Institute of Microbiology, Chinese Academy of Sciences, No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing.

[0036] Example 2

[0037] Obtaining Bacillus belyss LMY3-5 involves the following steps:

[0038] Step 1: Separation

[0039] Using the plate dilution method, rinse the kiwifruit thoroughly, soak it in 70% ethanol for 30 seconds, rinse it three times with sterile water, disinfect it with 2% sodium hypochlorite for 3 minutes, and then rinse it 4-5 times with sterile water. Grind the whole kiwifruit in a sterile mortar, collect the supernatant, and dilute it with sterile water at a ratio of 10:1. -2 10 -3 Dilute it according to the specified ratio and spread it on LB solid medium. Incubate it upside down in a dark incubator at 37°C for 24 hours. Pick different single colonies and repeatedly purify them on LB medium using the streak method. Then preserve them in glycerol.

[0040] The second step is initial screening.

[0041] Using *Bacillus dothidea*, the pathogen causing soft rot of kiwifruit, as the target bacterium, the activity of isolated and purified bacteria was screened using the plate confrontation method. A 0.5 cm diameter cake of *Bacillus dothidea* was inoculated in the center of a PDA plate. Using the center of the plate as the center, a loopful of bacteria was inoculated at four equidistant locations 2.5 cm from the center. The plates were incubated at 28°C for 7 days. A control group was also included, and the inhibition radius of the biocontrol bacteria was recorded. Strains with an inhibition zone radius greater than 1.0 cm were selected as candidate strains for secondary screening.

[0042] Through initial screening, a total of 14 bacterial strains with initial screening activity were obtained, numbered 5, 17, 18, 23, 29, 32, 33, 36, 37, 39, 40, 45, 61, and 62, as shown in Table 1.

[0043] Table 1. Radius of inhibition zone of initially screened strains

[0044]

[0045] Third step: rescreening

[0046] Fourteen strains with inhibition zone radii greater than 1.0 cm from the initial screening were streaked onto LB agar to form single colonies. One loopful of each single colony was picked and placed in 50 mL of LB liquid medium, then incubated at 28°C with shaking for 2 days. Using *Bacillus dothidea*, the pathogen causing soft rot of kiwifruit, as the target bacterium, *Bacillus dothidea* mycelial discs activated for 7 days were inoculated into the center of PDA agar. Five μL of the same strain was inoculated at two equidistant locations 2.5 cm away from the center, serving as a control. The agar was incubated at 28°C until the control colonies covered the entire plate. The diameter of the pathogen colonies was measured, and the inhibition rate was calculated. The strain with the highest inhibition rate was identified as *Bacillus belyssiensis* LMY3-5. The inhibition rate was calculated using the formula: Inhibition rate (%) = [(Control group colony diameter - Treatment group colony diameter) / Treatment group colony diameter] × 100.

[0047] The 14 biocontrol strains screened initially had inhibition rates ranging from 56.35% to 70.63%. Among them, strain number 3-5 (i.e., LMY3-5) showed the best activity, with a mycelial growth inhibition rate of 70.63%, as shown in Table 2.

[0048] Table 2 Inhibition rate of secondary screening strains

[0049] strain number Inhibition rate (%) 3-5 70.63±0.69a 3-17 65.48±1.19abc 3-18 62.30±2.75cde 3-23 68.65±0.69ab 3-29 58.73±0.69ef 3-32 61.90±1.19cde 3-33 60.71±1.19cdef 3-36 61.51±2.48cdef 3-37 56.35±1.82f 3-39 64.29±2.06bcd 3-40 60.32±1.37cdef 3-45 59.92±1.37def 3-61 60.32±2.94cdef 3-62 60.12±1.57def

[0050] Example 3

[0051] The identification of Bacillus bereaves LMY3-5, including morphological and molecular biological identification, is as follows:

[0052] Step 1: Cell staining and morphological observation

[0053] Strawberry strain LMY3-5 was activated by streaking on LB agar plates and incubated overnight at 37°C. Its morphology, color, size, and other characteristics were observed and photographed. The strain was stained using Gram staining and observed under a microscope.

[0054] The results showed that after culturing on LB solid medium for 24 hours, strain LMY3-5 formed milky white colonies with a rough, wrinkled surface and irregular, opaque edges. Figure 1 A). In Gram staining, the staining result is purple, indicating that strain LMY3-5 is a Gram-positive bacterium. Figure 1 B).

[0055] Step 2 Molecular biological identification

[0056] DNA was extracted from the biocontrol strain following the procedures outlined in the Biomiga Bacteria DNA Kits extraction kit. Using the obtained DNA as a template, 16S rRNA gene primers (upstream primer: 5'-AGAGTTTGATCCTGGCTCAG-3', downstream primer: 5'-GGTTACCTTGTTACGACTT-3') and gyrA gene primers (upstream primer: 5'-CAGTCAGGAAATGCGTACGTCCT, downstream primer: 5'-CAAGGTAATGCTCCAGGCATTGCT-3') were used to amplify the endophytic bacterial 16S rRNA and gyrA sequences, respectively. The PCR products were sent to Sangon Biotech (Shanghai) Co., Ltd. for sequencing. Sequence alignment was performed using GenBank in NCBI, and highly homologous sequences were downloaded from the GenBank database as reference sequences. A phylogenetic tree was constructed using MrBaye and RaxML on the CIPRES ScienceGateway V.3.3 website. The resulting tree file was viewed using FigTree v.1.4.0.

[0057] The results showed that the 16S rRNA and gyrA sequences of strain LMY3-5 were submitted to NCBI and obtained accession numbers PP231028 and PP239377, respectively. Blast alignment of the sequenced 16S rRNA and gyrA genes was performed, and the corresponding sequences of 19 highly homologous Bacillus strains were selected as reference sequences for multigene phylogenetic analysis. Strain LMY3-5 clustered with Bacillus velezensis in one clade, with a support ratio of 100 / 1. Based on the combined morphological and molecular phylogenetic results, strain LMY3-5 was identified as Bacillus velezensis.

[0058] Example 4: Preparation of Bacillus belyss LMY3-5 fermentation broth

[0059] The LMY3-5 strain, preserved on glycerol, was activated by streaking on LB solid medium. One loop of each activated single colony was inoculated into 50 mL of LB liquid medium and cultured at 30°C with shaking at 200 rpm for 24 h to obtain the seed culture. 5 mL of the seed culture was inoculated into 100 mL of LB liquid medium and cultured at 30°C with shaking at 200 rpm for 3 days. The supernatant was collected by centrifugation at 12000 rpm for 15 min and then sterilized at 121°C for 30 minutes to obtain the fermentation broth.

[0060] The LB solid culture medium formula is as follows: 5g yeast extract, 10g peptone, 5g NaCl, 17g agar, and 1000mL distilled water. Sterilize at 121℃ for 30 minutes.

[0061] The LB liquid culture medium formula is as follows: 5g yeast extract, 10g peptone, 5g NaCl, and 1000mL distilled water. Sterilize at 121℃ for 30 minutes.

[0062] Example 5: Inhibition of mycelial growth of *Bacillus belyssus* LMY3-5 fermentation broth on kiwifruit soft rot pathogen.

[0063] Add 1%, 2%, 4%, 8%, and 16% (v / v) of LMY3-5 fermentation broth to PDA medium cooled to approximately 50°C, respectively. Mix thoroughly to prepare plates, using blank PDA as a control. Inoculate the center of each plate with a pathogenic bacterial pellet and incubate at 28°C. Repeat three times. After the mycelia in the blank PDA have fully colonized the plate, measure the colony diameter and calculate the inhibition rate; Inhibition rate (%) = [(Coronary diameter of control group - Colony diameter of treatment group) / Colony diameter of control group] × 100;

[0064] Results: The fermentation broth of strain LMY3-5 significantly inhibited the mycelial growth of B. dothidea and D. eres. Figure 2 As the concentration of fermentation broth in the culture medium increases, its antibacterial activity gradually increases. When the fermentation broth concentration reaches 16%, the inhibition rates against pathogens B. dothidea and D. eres reach 83.51% and 80.68%, respectively (Table 3).

[0065] Table 3. Inhibitory effect of fermentation broth from strain LMY3-5 on the mycelial growth of B. dothidea and D. eres.

[0066]

[0067] Example 6: Inhibition of spore germination by Bacillus belyss LMY3-5 fermentation broth on kiwifruit soft rot pathogen.

[0068] Scrape conidiophores formed on B. dothidea plates and dilute with sterile water to a concentration of 1×10⁻⁶. 6 mL -1 Spore suspension. Take 1 mL each of the fermentation broth from Example 4 and the spore suspension of B. dothidea, mix well, and use sterile LB medium as a control. Incubate at 28℃ for 12 h. Observe the germination of pathogen spores in the two treatment groups under an optical microscope. Each treatment is repeated 3 times. Count and compare the spore germination rate and spore germination inhibition rate.

[0069] Spore germination rate (%) = Number of germinating spores / Total number of spores × 100

[0070] Spore germination inhibition rate (%) = (germination rate of control group – germination rate of treatment group) / germination rate of control group × 100.

[0071] Results: When the fermentation broth addition amount was 16.00% (volume ratio), the inhibitory effect of the antagonistic bacteria LMY3-5 fermentation broth reached its maximum. Figure 3 The lowest spore germination rate was only 2.47%, with a spore germination inhibition rate of 97.32% (Table 4). Next, the 8.00% (v / v) and 4.00% (v / v) fermentation broth treatment groups showed spore germination rates of 25.11% and 42.72%, respectively, and spore germination inhibition rates of 72.76% and 53.65%, respectively (Table 4). This indicates that the LMY3-5 fermentation broth can effectively inhibit the spore germination of *B. dothidea*, and the inhibitory effect of strain LMY3-5 on spore germination becomes increasingly stronger with increasing fermentation broth concentration in the PDB medium.

[0072] Table 4. Inhibitory effect of LMY3-5 fermentation broth on B. dothidea spore germination.

[0073]

[0074] Example 7: Efficacy of Bacillus vesicularis LMY3-5 fermentation broth on kiwifruit

[0075] Select fresh, healthy kiwifruit of uniform size, disinfect the surface, and puncture three wounds on the surface of each kiwifruit with a sterile toothpick. Immerse the kiwifruit in the fermentation broth of Example 4 at concentrations of 1%, 2%, 4%, 8%, and 16%, respectively, for 60 minutes. After removal, place them in sterile petri dishes to air dry naturally. Inoculate the kiwifruit wounds with pathogenic fungal cakes, using sterile water soaking followed by pathogen inoculation as a control. Ten kiwifruit were used for each treatment and incubated in a 28℃, 90% relative humidity incubator. After 7 days, the diameter of the lesions was measured. Fruit lesion inhibition rate (%) = (diameter of lesions in the control group – diameter of lesions in the treatment group) / diameter of lesions in the control group × 100.

[0076] Results: Kiwifruit in the control group (without fermentation solution) showed severe disease, with large lesions and fruit rotting. Kiwifruit treated with fermentation solution showed milder disease and smaller lesions. Higher fermentation solution concentration resulted in smaller lesion diameters and better inhibitory effects. Figure 4 (Table 5). Kiwifruit treated with 16% fermentation broth showed inhibition rates of 73.59% and 73.39% against *B. dothidea* and *D. eres*, respectively. Figure 4 (Table 5). The results showed that strain LMY3-5 could effectively inhibit the infection of B. dothidea and D. eres, slow down the spread of lesions, and had a significant control effect on soft rot of kiwifruit.

[0077] Table 5. Inhibitory effect of LMY3-5 fermentation broth on fruit lesions of B. dothidea and D. eres

[0078]

[0079] Example 8: Observation of the mycelial morphology of Bacillus dothidea in fermentation broth of Bacillus belyss LMY3-5

[0080] The mycelial morphology of *B. dothidea* was observed using a scanning electron microscope (SEM) (SU-8010, Hitachi, Tokyo, Japan). Mycelia of the pathogen, collected from the fermentation broth of Example 4 and treated for 12 h, were completely immersed in glutaraldehyde fixative overnight at 4°C. After discarding the fixative, the sample was rinsed three times with phosphate buffer (0.1 M, pH 7.2), 15 min each time. Then, a gradient dehydration process was performed using 30%, 50%, 70%, 80%, 90%, and 100% ethanol, 20 min each time. The sample was then immersed twice in isoamyl acetate, 30 min each time, and freeze-dried under vacuum before observation and image acquisition under a scanning electron microscope.

[0081] The results are as follows Figure 5The results showed that the CK mycelium surface was plump and intact, without wrinkles or depressions, and of uniform thickness; after treatment with the fermentation broth, the mycelium surface began to show structural abnormalities, collapse, wrinkling, and breakage. Therefore, the fermentation broth damaged the cell walls and membrane structures of the mycelium, affecting the normal physiological metabolic activities of the mycelium, leading to the mycelium becoming shriveled, wrinkled, and gradually dying.

[0082] Example 9: Observation of the ultrastructure of B. dothidea cells from Bacillus belyss LMY3-5 fermentation broth

[0083] The microstructure of *B. dothidea* cells was observed using a transmission electron microscope (TEM) (EM1200EX, JEOL). Samples were prepared as in Example 8, subjected to a gradient dehydration treatment with 30%, 50%, 70%, 80%, 90%, and 100% ethanol, followed by treatment with pure acetone solution for 20 min. The samples were then embedded in Epon 812 fixative, ultrathinly sectioned, and double-stained with uranium acetate and lead citrate before observation and image acquisition using a transmission electron microscope.

[0084] The results are as follows Figure 6 The results showed that the mycelial cells untreated with the fermentation broth from Example 4 remained healthy, with normal cell wall and cell membrane shapes, clear organelle outlines, and uniform distribution in the cytoplasm. Conversely, after 12 hours of treatment with the fermentation broth, the mycelial cell structure was incomplete, with blurred cell wall outlines, cell membrane shrinkage, loose internal structure, severe organelle dissolution, and large areas of cavities. This indicates that the fermentation broth from Example 4 damaged the *B. dothidea* cell structure, harmed the cell membrane, increased cell membrane permeability, leakage of contents, and decreased cytoplasmic density, thus restricting the growth and development of *B. dothidea* mycelia and even causing death.

[0085] Example 10: Determination of PI staining of Bacillus dothidea in fermentation broth of B. dothidea LMY3-5

[0086] The mycelium of the pathogenic bacterium (B. dothidea) treated with the fermentation broth of Example 4 for 12 h was added to 500 μL of 1 mg / mL PI staining solution, and incubated in a water bath at 30°C in the dark for 30 min. Excess staining solution was washed off with PBS. Images were observed and acquired using a confocal fluorescence microscope (NE910-FL, Ningbo Yongxin Optics Co., Ltd., Zhejiang).

[0087] The results showed that propidium iodide (PI) could penetrate the cell membranes of dead cells and late-stage apoptotic cells, staining the cell nuclei and providing a direct visual indication of the degree of damage to the hyphal cell membrane. For example... Figure 7As shown, after 12 hours of treatment with the fermentation broth, *B. dothidea* hyphae exhibited red fluorescence under a fluorescence microscope, and the intensity of the red fluorescence increased with increasing fermentation broth concentration. The results indicate that the fermentation broth significantly disrupts the cell membrane integrity of *B. dothidea*. Figure 7 ).

[0088] Example 11 Assay of intracellular contents release from Bacillus belyssus LMY3-5 in B. dothidea cells

[0089] B. dothidea was cultured in 150 mL PDB with shaking for 3 days. The culture medium was removed by filtration in a clean bench, and the wet mycelium was collected. An equal amount of mycelium (1 g) was weighed and resuspended in PDB medium containing 1%, 2%, 4%, 8%, and 16% (v / v) of the fermentation broth from Example 4. The mycelium was treated for 0.5 h, 1 h, 3 h, 6 h, 12 h, and 24 h, respectively. After centrifugation at 6000 rpm for 15 min, the supernatant was collected and the absorbance at 260 nm and 280 nm was measured using a multi-functional microplate reader (SuperMax 3100, Shanghai Flash Spectrum Biotechnology Co., Ltd.). Each treatment was repeated 3 times, and the relative leakage of nucleic acids and proteins was calculated.

[0090] Nucleic acids and proteins are important cellular components and indicators of cell membrane permeability. For example... Figure 8 As shown, the content of extracellular proteins and nucleic acids in the pathogenic bacteria increased with prolonged treatment time and increased fermentation broth concentration, while the CK group showed little change. After 6 hours of fermentation broth treatment, large amounts of nucleic acids and proteins began to leak from the B. dothidea mycelial cells. This indicates that the fermentation broth disrupted the cell membrane, increased cell membrane permeability, and led to a dose-dependent increase in the leakage of nucleic acids and proteins.

[0091] Example 12: Determination of B. dothidea cell wall enzymes from Bacillus belyss LMY3-5 fermentation broth

[0092] Mycelia were prepared according to the method in Example 11. Equal amounts of mycelia (1g) were weighed and resuspended in PDB medium containing 1%, 2%, 4%, 8%, and 16% (v / v) of the fermentation broth from Example 4 for 3h, 6h, 12h, 24h, 48h, and 72h, with each treatment repeated three times. Crude extracts were obtained according to the instructions for the β-1,3-glucanase and chitinase activity assay kits, and their enzyme activities were detected using a multi-functional microplate reader (SuperMax 3100, Shanghai Flash Spectrum Biotechnology Co., Ltd.).

[0093] The results showed that the activities of β-1,3-glucanase and chitinase in *B. dothidea* initially increased and then decreased. Chitinase activity reached its maximum after 12 hours of treatment, while β-1,3-glucanase activity reached a relatively high level after 24 hours. Furthermore, at all measurement time points, the activities of both β-1,3-glucanase and chitinase in *B. dothidea* treated with the fermentation broth were significantly higher than those in the control. This indicates that the fermentation broth induced an increase in the activity of key cell wall enzymes, leading to the gradual degradation of the cell wall. Figure 9 ).

[0094] Example 13 Identification of components in Bacillus belyssus LMY3-5 fermentation broth by GC / LC-MS

[0095] The components of the fermentation broth from Example 4 were identified using GC / LC-MS. GC-MS was performed using an Agilent 7890B gas chromatograph coupled with an Agilent 5977B mass spectrometer (MS) (Agilent Technologies, USA), employing a DB-5MS capillary column (30m × 0.25mm, 0.25μm film thickness) for identification of the LMY3-5 fermentation broth components. LC-MS analysis was performed using API 2000. TM (AB Sciex, Redwood City, CA, USA), eluted with a water / acetonitrile mobile phase containing 0.05% TFA. Mass spectrometry analysis was performed using a triple quadrupole spectrometer equipped with an electrospray ionization (ESI) source.

[0096] GC-MS results identified 181 differentially expressed metabolites. According to literature reports, 12 of these metabolites exhibited antibacterial activity (see Table 6).

[0097] LC-MS results showed that 1508 compounds were detected in the positive spectrum, of which 122 had a score of 80 or higher. 1393 compounds were detected in the negative spectrum, of which 82 had a score of 80 or higher. According to literature reports, 17 metabolites showed antibacterial activity (see Table 7).

[0098] Table 6. GC-MS analysis of antibacterial active substances in LMY3-5 fermentation broth

[0099]

[0100]

[0101] Table 7. LC-MS analysis of antibacterial active substances in LMY3-5 fermentation broth

[0102]

[0103]

[0104]

[0105] Example 14: Antibacterial activity of Bacillus belyssus LMY3-5 against multiple pathogens

[0106] One loop of biocontrol bacterium LMY3-5 was picked and placed in 50 mL of LB liquid medium, then incubated at 28℃ and 200 rpm for 2 days to obtain LMY3-5 bacterial suspension. Using *Actinidia dothidea*, *D. eres*, *M. fructicola*, *A. alternata*, and *C. gloeosporioides* as target pathogens, mycelial plugs (0.5 cm in diameter) of activated pathogens were inoculated into the center of PDA medium. 5 μL of LMY3-5 bacterial suspension was inoculated at two equidistant positions (2.5 cm apart) on the plug. A control was prepared by inoculating only the center of the PDA medium. The mixture was incubated at 28℃ until the control colonies covered the entire plate. The diameter of the pathogen colonies was measured, and the inhibition rate was calculated.

[0107] The formula for calculating the inhibition rate is: Inhibition rate (%) = [(Coronavirus diameter of control group - Coronavirus diameter of treatment group) / Coronavirus diameter of treatment group] × 100;

[0108] The inhibitory effects of Bacillus belyifolia LMY3-5 on the mycelial growth of kiwifruit soft rot (B. dothidea), kiwifruit soft rot (D. eres), Australian brown rot fungus (M. fructticola), cruciferous black spot fungus (A. alternata), and tea anthracnose fungus (C. gloeosporioides) were observed. The results are shown in Table 8. Figure 10 As shown.

[0109] Table 8. Inhibition rate of Bacillus belye LMY3-5 on mycelial growth of various pathogens

[0110]

Claims

1. A Bacillus Velez, characterized in that The strain was named Bacillus velezensis LMY3-5 and deposited in the General Microbiology Center of China Culture Collection Administration with the deposit number CGMCC N0:29700.

2. The fermentation liquid of Bacillus Velezii as claimed in claim 1.

3. The secondary metabolites produced by fermentation of Bacillus Velezii as claimed in claim 1.

4. Use of the Bacillus Velez subtilis according to claim 1 or the fermentation liquid according to claim 2 in preparing a preparation for inhibiting plant pathogens, characterized in that: The plant pathogens are kiwifruit soft rot fungi (Botryosphaeriadothidea), kiwifruit soft rot fungi (Diaporthe eres), American and Australian stone fruit brown rot fungi (Moniliniafructicola), Cruciferae black spot fungi ( Alternaria alternata ), tea anthracnose fungus (Colletotrichum gloeosporioides).

5. Use of the Bacillus Velez subtilis according to claim 1 or the fermentation liquid according to claim 2 in preparing a preparation for preventing and treating diseases caused by plant pathogens, characterized in that: The plant pathogens are Botryosphaeria dothidea, Diaporthe eres, Monilinia fructicola, and Cruciferae black spot ( Alternariaalternata ), tea anthracnose fungus (Colletotrichum gloeosporioides).

6. Use of the Bacillus Velez subtilis according to claim 1, the fermentation liquid according to claim 2, or the secondary metabolite according to claim 3 in the preparation of a preparation for preventing and treating kiwifruit rot.

7. A biocontrol agent comprising the Bacillus Velezii according to claim 1, and / or the fermentation broth according to claim 2, and / or the secondary metabolite produced by fermentation according to claim 3.

Citation Information

Cited By

  • Bacillus tequilensis P61 and application of bacillus tequilensis P61 in prevention and treatment of kiwi fruit soft rot

    CN120272359A

  • Composting bacillus DX-10 and application thereof

    CN120866153A

  • Bacillus composti DX-10 and application thereof

    CN120866153B